Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effectsDavid P. Dearnaley(Royal Marsden NHS Foundation Trust), Alan Horwich(Institute of Cancer Research)British Journal of CancerFebruary 1, 200510.1038/sj.bjc.6602301Cited by 230SaveCiteExport RISWatch citationsRelated PapersPre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer|British Journal of Cancer|2002|16